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Recently, we showed that endothelial heparan sulfate facilitates entry of a bacterial pathogen into the central nervous system.
Here, we show that normal bactericidal activity of neutrophils is influenced by the sulfation pattern of heparan sulfate. Inactiva-
tion of heparan sulfate uronyl 2-O-sulfotransferase (Hs2st) in neutrophils substantially reduced their bactericidal activity, and
Hs2st deficiency rendered mice more susceptible to systemic infection with the pathogenic bacterium group B Streptococcus.
Specifically, altered sulfation of heparan sulfate in mutant neutrophils affected formation of neutrophil extracellular traps while
not influencing phagocytosis, production of reactive oxygen species, or secretion of granular proteases. Heparan sulfate pro-
teoglycan(s) is present in neutrophil extracellular traps, modulates histone affinity, andmodulates their microbial activity.
Hs2st-deficient brain endothelial cells show enhanced binding to group B Streptococcus and are more susceptible to apoptosis,
likely contributing to the observed increase in dissemination of group B Streptococcus into the brain of Hs2st-deficient mice fol-
lowing intravenous challenge. Taken together, our data provide strong evidence that heparan sulfate from both neutrophils and
the endothelium plays important roles in modulating innate immunity.
Heparan sulfate (HS) proteoglycans (HSPGs) are ubiquitouslyexpressed by animal cells and play essential roles in cell sig-
naling and cell-cell interactions (1, 2). To a large extent, these
properties depend on the interaction of HS with various signaling
receptors and their ligands (3). Many pathogens have evolved to
exploit cell surface HS molecules as counterreceptors for adhesion
and invasion (4–7). Cell surface HSPGs also modulate the innate
immune response by regulating chemokine presentation and
growth factor responses (8). Thus, HSPGs lie at a nexus between
pathogen invasion and host defense.
Neutrophils, the most abundant circulating leukocyte, repre-
sent a critical first line of mammalian host defense against a wide
range of infectious pathogens. Neutrophils are recruited to sites of
infection, recognize and phagocytose microbes, and kill patho-
gens through a combination of microbicidal mechanisms, includ-
ing production of reactive oxygen species, release of antimicrobial
peptides, and expulsion of their nuclear contents to form neutro-
phil extracellular traps (NETs) (9, 10). HS modulates the rapid
recruitment of neutrophils to sites of infection or injury at differ-
ent levels, in particular through its interactions with cytokines,
chemokines, and selectins (8). We reported previously that re-
duced expression and altered sulfation of HS on endothelial cells,
achieved by inactivating glucosamine N-deacetylase-N-sulfo-
transferase-1 (Ndst1) or uronyl 2-O-sulfotransferase (Hs2st), al-
tered neutrophil extravasation to sites of sterile inflammation by
modifying interactions between endothelial HS and L-selectins on
neutrophils and chemokines released during the inflammatory
response (11, 12). In contrast, the same modifications of HS on the
neutrophil cell surface did not affect trafficking during sterile in-
flammation (11, 12) and had only mild effects on the acquired
immune responses (13). Here we extended this line of investiga-
tion to live-bacterial-infection models to probe how HS modifi-
cation can influence intrinsic neutrophil functions relevant to an-
tibacterial defense and microbicidal activity.
Several potential neutrophil bactericidal effectors, including
proteases (elastase and cathepsin G) and -defensins, have been
shown to interact with HSPGs and affect their intracellular local-
ization and retention within granules (14–16). During NET for-
mation at tissue foci of infection, antimicrobial effectors, includ-
ing elastase, cathepsin G, and strongly cationic histones, are
displayed across the chromatin-based network to act against bac-
teria ensnared in the extracellular structures (17, 18). The polyan-
ionic charge of HS should favor interaction with positively
charged histones with the potential to modulate their cytotoxic
effects (19–22). Thus, we sought to understand whether modifi-
cation of HS sulfation in neutrophils could regulate their antimi-
crobial activity, especially in the context of NETs during in vivo
infection.
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Here we took advantage of conditional knockout mice in
which Hs2st is deleted in myeloid cells (including neutrophils)
and endothelial cells by excision of a loxP-flanked allele under the
control of Cre recombinase driven by the Tie2 promoter (Hs2stf/f
Tie2 Cre mice, referred to here as Hs2st-deficient or mutant
mice). Analysis of these animals revealed that neutrophil-derived
HS plays a significant role in controlling bactericidal activity.
Whereas inactivation of Hs2st on endothelial cells facilitates neu-
trophil infiltration to sterile inflammatory stimuli (11), the im-
paired intrinsic bactericidal activity of Hs2st-deficient neutrophils
results in increased susceptibility of Hs2st-deficient mice to inva-
sive bacterial infection. The bactericidal defect in Hs2st-deficient
mice correlates with reduced NET formation and altered histone
affinity to HS within the NETs.
MATERIALS AND METHODS
Bacteria and mouse strains. Human serotype V group B Streptococcus
(GBS) clinical isolate NCTC 10/84 (ATCC 49447) was propagated in
Todd-Hewitt broth (THB; Difco, BD Diagnostics) at 37°C without shak-
ing. For infection studies, bacteria were grown at to mid-exponential
phase, resuspended to an optical density at 600 nm (OD600) of 0.4 (2
108 CFU per ml), and serially diluted to the desired inoculum.Hs2stf/fTie2
Cre mice were generated as described previously (11) and back-
crossed 10 generations on a C57BL/6 background. Littermate Hs2stf/f
Tie2 Cre mice were used as wild-type controls in all experiments. Mice
were provided ad libitum with Nanopure water and PicoLab 5053 lab
chow.
Macrophage, neutrophil, and endothelial cell isolation and culture.
Murine bone marrow-derived macrophages (MBDMs) were derived
from cells collected from femur and tibia marrow and cultured with the
conditioned medium collected from L929 cells stably expressing macro-
phage colony-stimulating factors for 7 days. For neutrophil isolation from
murine bone marrow, cells were resuspended in ammonium-chloride-
potassium (ACK) lysis buffer to eliminate erythrocytes, resuspended in
45% Percoll (GE Healthcare Life Sciences), layered on discontinuous Per-
coll gradient solutions (50%, 55%, 62%, and 81%), and centrifuged for 30
min at 1,200 g without a centrifugal brake. Neutrophils were collected
from the 62%-81% interface, washed twice with phosphate-buffered sa-
line (PBS), and resuspended in RPMI 1640 containing 2% fetal bovine
serum (FBS) for experiments. Neutrophil purity was consistently 85 to
95% as determined by flow cytometry performed with fluorescein isothio-
cyanate (FITC)-conjugated anti-Gr-1 monoclonal antibody (MAb)
(clone RB6-8C5; Caltag Medsystems). For lipopolysaccharide (LPS)-elic-
ited peripheral neutrophils, dorsal air pouches were created by subcuta-
neous injection of mice with 2.5 ml of sterile air twice every 3 days over a
1-week period. LPS (2 g) in 0.6 ml 0.5% carboxymethyl cellulose solu-
tion (sodium salt; Sigma) was injected into the pouch to recruit neutro-
phils. Four hours after LPS injection, pouches were lavaged with PBS
containing 3 mM EDTA to extract neutrophils; purity was90% by flow
cytometry. Murine brain microvascular endothelial cells (BMECs) were
isolated from the cerebral cortex as described previously (23), except that
cells were selected with 5 g/ml puromycin for 4 days in low-glucose
Dulbecco’s modified Eagle medium (DMEM) containing 20% FBS, 50
g/ml endothelial cell growth supplement (Biomedical Technologies,
Inc.), 50g/ml heparin (Sigma), nonessential amino acids, penicillin, and
streptomycin. Cell purity was 98% as assessed by blood endothelial
markers (CD31, CD34, CD105, and CD166).
Murine whole blood bactericidal assay. Whole blood was collected
by cardiac puncture from euthanized mice with lepirudin to prevent co-
agulation and to avoid potential confounding effects of heparin in the
assay. Blood (300 l) was mixed with 104 CFU of GBS (in 100 l) and
incubated at 37°C in a siliconized microtube under rotation (n 	 2 or 3
biological replicates). Twenty-five microliters of the mixture was removed
at various time points to enumerate CFU of surviving bacteria.
BMDM bactericidal activity and cytokine release. For bacterial kill-
ing, 105 CFU of the GBS strain NCTC 10/84 were added to 5  105
BMDMs (multiplicity of infection [MOI] 	 0.2) for 1 h; then 50 l of
0.6% Triton X-100 was added to lyse cells. The number of CFU of GBS
recovered was determined. To detect cytokine secretion after GBS infec-
tion, 105 macrophages were stimulated for 30 min with GBS (MOI	 1),
followed by addition of penicillin (5g/ml) and gentamicin (10g/ml) to
prevent bacterial overgrowth. Culture supernatants were collected 24 h
after infection, and secretion of tumor necrosis factor alpha (TNF-) and
interleukin 6 (IL-6) was analyzed by enzyme-linked immunosorbent as-
say (ELISA) (BD Biosciences). For quantitative RT-PCR analysis, RNA
was isolated from BMDMs using TRIzol (Life Technologies) 30 min after
GBS stimulation (MOI	 10) and used as a template for cDNA prepara-
tion by iScript (Bio-Rad). Quantitative PCR was performed using iQ
SYBR green supermix (Bio-Rad) per standard protocols. Primer combi-
nations were as follows: for IL-1
, 5=-ACTACAGGCTCCGAGATGAA
C-3= plus 5=-CCCAAGGCCACAGGTATTTT-3=; for TNF-, 5=-AGCCC
ACGTCGTAGCAAACCACCAA-3= plus 5=-ACACCCATTCCCTTCAC
AGAGCAAT-3=; for GAPDH, 5=-AACTTTGGCATTGTGGAAGGGC-3=
plus 5=-GGTAGGAACACGGAAGGCCATG-3=. Primers for IL-10 were
obtained from the QuantiTect primer assay (Qiagen).
Neutrophil bactericidal activity and extracellular-trap (NET) for-
mation. For bactericidal assays, murine bone marrow neutrophils were
pretreated with 160 M phorbol myristate acetate (PMA) for 90 min,
whereas LPS-elicited neutrophils were used directly upon isolation. GBS
(2 105 CFU) were added to 106 neutrophils (MOI	 0.2) and incubated
at 37°C with rotation in a siliconized microtube; CFU were measured in
25-l aliquots at various time points to enumerate surviving GBS. To
quantify NET formation after GBS infection, LPS-elicited neutrophils
were resuspended in RPMI 1640 containing 2% FBS at a density of 2 106
cells/ml, and 2 105 cells (100 l) were transferred to a well of a 96-well
microtiter plate containing 2 106 CFU GBS in 100 l. Plates were cen-
trifuged at 1,600 rpm for 5 min to initiate bacterial-cell contact and sub-
sequently incubated for 2 h. Neutrophils were then washed with PBS,
fixed with 4% paraformaldehyde, blocked with 2% BSA–PBS, and stained
with anti-H2B rabbit polyclonal antibody (1 g/ml; GenScript) followed
by Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody (Life Tech-
nology) to visualize NET formation. Images were acquired using an in-
verted confocal microscope Olympus FV1000 with Fluoview spectral
scanning technology (Olympus). For human NET-mediated bactericidal
assays, human neutrophils were isolated from healthy donors by Poly-
morphprep (Axis-Shield) gradient centrifugation, resuspended to 5 
106/ml in serum-free RPMI 1640 medium, and stimulated with 25 nM
PMA (Sigma) for 3 h to induce NET formation. NETs were then digested
with DNase I (10 U/ml; Worthington Biochemical Corp.) or heparan
lyase I and III (each 5 mU/ml) at 37°C for 30 min and gently rinsed once
with PBS. GBS (5  105 CFU) were added to the NETs, centrifuged to
initiate contact, and incubated for 30 min at 37°C. Surviving GBS were
enumerated by serial plating on Todd-Hewitt broth agar (THA) plates. To
visualize heparan sulfate on NETs, human neutrophils were stimu-
lated with 25 nM PMA for 3 h to induce NET formation. Cells were
then treated with heparan lyase III (5 mU/ml) at 37°C for 20 min, fixed,
and stained with mouse anti-heparan sulfate neoepitope MAb (3G10;
US Biological) or rabbit anti-human myeloperoxidase PAb (Dako),
followed by Alexa Fluor 488-conjugated goat anti-mouse Abs (Life
Technology) or Alexa Fluor 594-conjugated goat anti-rabbit Abs (Life
Technology) and DAPI (4=,6=-diamidino-2-phenylindole).
BMEC bacterial binding and apoptosis assays. BMECs were grown
to confluence in 24-well plates, infected with 2 106 CFU GBS per well,
and centrifuged at 1,600 rpm for 5 min to initiate bacterial-cell contact.
After 30 min of incubation and extensive washes with PBS, cells were
disrupted using 0.025% Triton X-100, and surviving bacterial CFU were
quantified by serial dilution plating. To assess GBS-induced apoptosis of
BMECs, cells were infected as described above, except that 100 g/ml of
gentamicin and 5 g/ml of penicillin G were added to prevent bacterial
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overgrowth. Cells were cultured for 4 h or 24 h, and apoptotic cells were
stained by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-
biotin nick end labeling) assay using a kit (BD Biosciences). Data were
acquired using BD FACSCalibur and analyzed by CellQuest software.
Western blot analysis. Murine BMDMs were stimulated with GBS
(MOI	 5) for 30 min and then lysed in buffer containing 50 mM Tris (pH
8), 150 mM NaCl, 1% NP-40, protease inhibitor cocktail (Roche), and
phosphatase inhibitor cocktail (Santa Cruz Biotechnology). Neutrophils
were stimulated with 160 nM PMA for 1 h or 2 h before collection of cell
lysates and supernatants. Samples were separated on SDS-PAGE and
transferred to a polyvinylidene difluoride (PVDF) membrane. The mem-
brane was probed with antibodies recognizing phospho-JNK (Cell Signal-
ing Technology), IB (Cell Signaling Technology), followed by appropri-
ate horseradish peroxidase (HRP)-conjugated secondary Abs (Bio-Rad)
and enhanced chemiluminescence reagent (Thermo Scientific).
Mouse infection studies. All animal experiments were performed us-
ing accepted veterinary standards on protocols approved by the UCSD
Committee on the Use and Care of Animals. To monitor survival after
systemic GBS challenge, mice (10 to 12 weeks old) were infected by in-
trperitoneal (i.p.) injection with 1.5  108 GBS and observed for 8 days.
For determination of bacterial organ dissemination and serum cytokine
secretion, mice were infected i.p. with 5 107 GBS, and spleens, kidneys,
and blood were harvested aseptically 18 h postinfection. Serum concen-
trations of IL-6, IL-1
, and MCP-1 were measured by ELISA (BD Biosci-
ences). In the meningitis model, mice (10 to 12 weeks old) were infected
intravenously (i.v.) with 1.4 108 GBS, and the number of bacterial CFU
in the blood was examined 4 h later to ensure sure similar initial bacterial
burdens. Mice were euthanized 18 h after infection, and samples of blood,
brain/meninges, lung, spleen, and kidney were collected aseptically. Bac-
terial CFU in blood and tissue homogenates were determined by serial
dilution plating. Bacterial counts in brain were corrected for their weight
differences. Brains collected from infected mice were fixed with 4% for-
malin, paraffin embedded, and sectioned for hematoxylin-and-eosin
(H&E) and Gram staining.
Neutrophil phagocytosis assay. Heat-killed GBS were labeled at
room temperature for 1 h with pH-sensitive pHrodo red succinimidyl
ester (Life Technology) using a 1 mM final dye concentration. Fresh blood
(250 l), treated with lepirudin as an anticoagulant, was incubated with
2.5  106 labeled GBS (MOI, 100) at either 37°C or 4°C for 1 h with
rotation. Samples were treated with ACK lysis buffer (Mediatech, Inc.) to
remove erythrocytes and fixed with 2% paraformaldehyde. Preparations
were then stained using allophycocyanin (APC)-conjugated rat anti-
mouse Ly6G (clone 1A8; BD Biosciences) for 10 min and subjected to
fluorescence-activated cell sorting (FACS). The final graph was prepared
by gating the Ly6G-positive cell population.
Histone binding assay. Monolayers of cultured primary lung endo-
thelial cells derived from wild-type (WT) andHs2stf/fTie2 Cremice were
detached using Accutase (Millipore) and incubated with human H2B or
H3 (5 g/ml; New England BioLabs) for 1 h in PBS at 4°C. The cells were
then incubated at 4°C for 1 h with rabbit anti-H2B IgG (2 g/ml; Gen-
Script) or rabbit anti-H3 IgG (1:200; Cell Signaling), followed by Alexa
Fluor 647-conjugated anti-rabbit IgG. Cells were subjected to flow cytom-
etry, and histone binding was assessed using FlowJo software (Tree Star,
Inc.). For neutrophil binding, whole blood from WT and Hs2stf/f Tie2
Cre mice was treated with ACK lysis buffer (Mediatech, Inc.) to remove
erythrocytes. The cells were then used to perform histone binding as de-
scribed above for endothelial cells. The cells were also stained with FITC-
conjugated Gr-1 antibody (Life Technology), and Gr-1-positive cells were
gated as neutrophils.
Scanning electron microscopy. Samples were fixed with glutaralde-
hyde and contrasted using repeated incubation with osmium tetroxide
and tannic acid. After dehydration in an ethanol series, samples were
critical-point dried, coated with a layer of carbon/platinum, and analyzed
FIG 1 Exacerbated mortality and bacterial dissemination in Hs2St-deficient mice. (A) Increased mortality of Hs2St-deficient mice after GBS challenge. Survival
of mice was monitored for 8 days after intraperitoneal (i.p.) infection with 1.5 108 CFU GBS. Data were pooled from two independent experiments (n	 19
for WT and n	 14 for Hs2St-deficient mice). Differences between groups were calculated by a log rank test. Mice were infected i.p. with 5 107 CFU of GBS and
then euthanized at 18 h postinfection for collection of organs for enumeration of bacterial CFU (B) and inflammatory cytokine ELISA (C). Data are medians with
interquartile ranges from one of the two independent experiments. Each circle denotes one mouse (n	 6/group). Differences between groups were calculated
by Mann-Whitney test (B and C).
Xu et al.
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at 10 kV in a LEO1550 field emission scanning electron microscope (Zeiss
SMT).
Statistical analysis. GraphPad Prism version 5 was used for statistical
analysis. Statistical significance was accepted at a P value of 0.05. Data
shown either were pooled from two independent experiments or are rep-
resentative data from 2 or 3 independent experiments conducted with
biological replicates. The significance of differences between different
groups for animal experiments was determined by Mann-Whitney test.
Unpaired t test was used to compare the difference between different 2
groups.
RESULTS
Hs2st-deficient mice are more susceptible to invasive bacterial
infection. Inactivation of Hs2st in endothelial cells (Hs2stf/f Tie2
Cre) increases neutrophil infiltration during acute sterile inflam-
mation (11), suggesting that Hs2st-deficient mice might resist in-
fection with live bacteria compared to wild-type animals. Surpris-
ingly, when mice were challenged by systemic intraperitoneal
infection with the human bacterial pathogen group B Streptococ-
cus (GBS), the mutant was dramatically more susceptible to infec-
tion (Fig. 1A). Notably, 79% (11 out of 14) of the Hs2st-deficient
mice died rapidly within the first 48 h, whereas the wild-type suc-
cumbed stepwise over the 8-day monitoring period (Fig. 1A).
To begin to ascertain contributing factors for the higher mor-
tality of Hs2st-deficient mice, animals were challenged with a
lower (sublethal) inoculum and the bacterial CFU in multiple
organs were measured. GBS dissemination was markedly in-
creased in Hs2st-deficient mice— both kidney and spleen CFU
counts were 2 to 3 orders of magnitude greater than those ob-
served in wild-type mice (Fig. 1B). Significantly enhanced serum
levels of the proinflammatory cytokines IL-6, IL-1
, and MCP-1
were observed in infected mutant mice (Fig. 1C). These observa-
tions indicate that Hs2st-deficient animals were capable of
mounting a proinflammatory cytokine response to GBS infection
but were less competent in limiting GBS growth or dissemination
in vivo.
GBS can invade brain microvascular endothelial cells (BMECs)
comprising the blood-brain barrier (BBB) to cause meningitis.
We showed previously that genetic impairment of HS expression
in flies or mice reduced GBS dissemination into the brain (24). To
examine how altering 2-O-sulfation might influence susceptibility
to GBS meningitis, we measured GBS dissemination into brain
after intravenous challenge (Fig. 2A). The number of CFU in the
brain was increased in the Hs2st-deficient mice compared to wild-
type mice at 18 h postinfection. Likewise, Hs2st-deficient mice
showed more profound histological evidence of meningeal cell
injury as well as increased neutrophil infiltration (Fig. 2B, middle)
and GBS dissemination (Fig. 2B, right) into the brain. In tissue
culture studies using primary BMECs isolated and prepared from
wild-type and Hs2st-deficient animals, we noted that adherence of
GBS to the mutant endothelial cells was 50% greater than that to
wild-type BMECs (Fig. 2C). Enhanced adhesion of GBS to Hs2st-
deficient BMECs correlated with a higher rate of apoptosis (50%
at 8 h) than that to wild-type BMECs (14% at 8 h) (Fig. 2D). This
finding is consistent with previous studies showing that adherence
and invasion of GBS into mammalian cells often provokes apop-
FIG 2 Increased GBS association and apoptosis of the Hs2st-deficient endothelial cells contributed to the GBS brain dissemination. Mice were intravenously
challenged with 1.4 108 CFU of GBS, and brains were collected 18 h after GBS infection to measure bacterial loads (A) or fixed in formalin for H&E staining
(B, left and middle; note the damage to the meninges) and Gram staining (B, right). Data are medians with interquartile ranges from one of the two independent
experiments, and each symbol denotes 1 mouse (n 	 6 for each group). (C) Increased GBS association with Hs2st-deficient mouse brain microvascular
endothelial cells (BMECs). Primary isolated BMECs were infected with GBS (MOI	 10) for 30 min, followed by extensive washing to remove unbound GBS.
Cell-associated GBS were enumerated by serial plating. Differences between the two groups were calculated by unpaired t test. (D) BMECs were infected with GBS
at an MOI of 10 for the indicated times, and apoptotic cells were detected by TUNEL assay. Representative data are from one of the 2 or 3 independent
experiments (C and D).
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tosis (25–28), which may result from more efficient delivery of its
cytolytic and proapoptotic 
-hemolysin/cytolysin toxin (29).
Wild-typeandHs2st-deficientmacrophages respondequally
to GBS stimulation. Hs2st deletion driven by the Tie2 promoter
targets myeloid cells as well as endothelial cells. To examine
whether loss of Hs2st influenced myeloid cell responses to bacte-
rial challenge, we inoculated fresh whole blood from wild-type
and Hs2st-deficient mice with GBS and measured bacterial sur-
vival over time. Within 2 h, CFU counts in Hs2st-deficient mouse
blood increased 6-fold over the initial inoculum, whereas prolif-
eration was controlled in wild-type blood (Fig. 3A). To determine
the innate immune cell(s) responsible for this difference in sus-
ceptibility, murine bone marrow-derived macrophages were
cocultured with GBS. Similar bactericidal capability was observed
for wild-type and mutant macrophages (Fig. 3B). As shown in Fig.
3C, c-Jun N-terminal kinase (JNK) phosphorylation and IB deg-
radation were similar as well, indicating a competent signaling
response of the Hs2st-deficient macrophages to GBS infection.
Furthermore, secretion of proinflammatory cytokines TNF- and
IL-6 in response to various Toll-like receptor stimuli, such as heat-
killed GBS, Pam2CKS4 (synthetic bacterial lipopeptides), and
LPS, was comparable in Hs2st-deficient macrophages and in wild-
type macrophages (Fig. 3D). At the transcriptional level, mRNA
expression for proinflammatory cytokines (TNF- and IL-1
)
and the anti-inflammatory cytokine IL-10 was also similar or
greater in Hs2st-deficient macrophages compared to wild-type
macrophages (Fig. 3E). All these observations suggest that Hs2st-
deficient macrophages are capable of detecting and responding to
bacterial challenge.
Hs2st-deficient neutrophils show reducedbactericidal activ-
ity and extracellular-trap formation. Neutrophils are the most
abundant pathogen-fighting myeloid cells in the circulation and
prominent first responders at infectious and inflammatory foci.
We hypothesized that dramatically increased GBS dissemination
in Hs2st-deficient mice could reflect a defect in Hs2st-deficient
neutrophil innate immune function(s). Indeed, Hs2st-deficient
bone marrow-derived neutrophils showed a significant defect in
bactericidal activity against GBS (Fig. 4A), in contrast to our find-
ings with bone marrow-derived macrophages (Fig. 3B). Dimin-
ished bactericidal activity was also observed for Hs2st-deficient
neutrophils collected from a dorsal air pouch after LPS-elicited
recruitment (Fig. 4B). Our previous study showed that both
Hs2stf/f Tie2 Cre mice reproduced normally, and no differences
in blood leukocyte counts were observed (11). The detail mor-
phology of unstimulated neutrophils was also examined under the
electron microscope, and we did not observe difference between
WT and Hs2st-deficient neutrophils (see Fig. S1 in the supple-
mental material). We next analyzed various neutrophil bacteri-
cidal functions. Bactericidal activities of neutrophils are multifac-
eted and include generation of reactive oxygen species (ROS),
release of granule proteases and antimicrobial peptides, phagocy-
tosis and killing within the phagolysosome, and formation of neu-
FIG3 Hs2st-deficient macrophages are competent to respond to bacterial challenge. (A) Increased replication of GBS in whole blood from Hs2St-deficient mice.
GBS (104 CFU) were incubated with blood collected from WT or Hs2St-deficient mice, and surviving bacteria were enumerated at the indicated time points by
serial plating. Data are representative of two independent experiments. (B) Similar bactericidal activity between WT and Hs2st-deficient macrophages. Mouse
bone marrow-derived macrophages (MBDMs) were infected with GBS at an MOI of 0.2, and surviving GBS were enumerated at the indicated time point by serial
plating. (C) MBDMs from WT and Hs2st-deficient mice were challenged with GBS for 30 min, and cell lysates were collected to analyze IB degradation and JNK
phosphorylation by Western blotting. (D) Macrophage cytokine secretion upon bacterial challenge. MBDMs were challenged with GBS, Pam2CKS4, and LPS for
24 h, and the culture supernatant from the stimulated macrophages was harvested for cytokine ELISA. (E) mRNA was collected from WT and Hs2st-deficient
macrophages after GBS stimulation to analyze cytokine transcript production by quantitative RT-PCR. Data are means standard errors of the means (SEM)
from one of 2 or 3 independent experiments. Differences between groups were calculated by an unpaired t test. ***, P 0.001; *, P 0.05 (A, B, D, and E).
Xu et al.
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trophil extracellular traps (NETs). We postulated that neutrophils
deficient in Hs2st must be crippled in one or more of these anti-
microbial mechanisms. Inactivation of Hs2st on the neutrophils
did not affect ROS generation (Fig. 4C), synthesis and release of
elastase (Fig. 4D), or phagocytic activity by neutrophils (Fig. 4E).
However, we observed that Hs2st-deficient neutrophils produced
fewer NETs after GBS stimulation, as quantified by immunostain-
ing using antibodies to the H2A/H2B complex and counting the
number of neutrophils connected by the NET strands (Fig. 4F).
Alteration of heparan sulfate affects histone binding capac-
ity. Since inactivation of Hs2st on the neutrophils reduced NET
formation, we asked if HS is present in NETs and whether altera-
tion of HS sulfation patterns could influence NET structure and
function. In subsequent experiments, we analyzed human neutro-
phils to determine the relevance of our findings in the mouse.
Compared to human neutrophils, mouse neutrophils make NETs
more slowly and less efficiently. Mouse neutrophils require 16 h to
undergo NETosis, and only about 30% of the stimulated cells
released NETs during this period. In contrast, it takes only 3 to 4 h
for 80% of the human neutrophils to make NETs (30). Freshly
isolated human neutrophils were stimulated with PMA to induce
NET formation and costained with MAbs specific for HS and my-
eloperoxidase (MPO). HS is physically present in normal NETs, as
revealed by colocalization of HS, MPO, and DNA straining (Fig.
5A). NETs treated with heparan lyase to eliminate HS showed
significantly reduced killing of GBS, an effect similar to degrading
the extracellular DNA backbone of the NETs with DNase (Fig.
5B). Thus, HS is a component of NETs whose presence is required
for NET-mediated bactericidal activity of neutrophils.
Scanning electron microscopy showed that although NETs
were diminished in Hs2st-deficient neutrophils, their ultrastruc-
tural characteristics were similar to those generated by wild-type
neutrophils. However, NETs from Hs2st-deficient neutrophils
had more attached globular domains (Fig. 5C), which may reflect
histones and other proteins associated with NETs. Consistent with
these data, we found that histones H2B and H3 showed greater
binding to HS expressed on the surface of Hs2st-deficient neutro-
phils than wild-type endothelial cells. The relative fluorescence
units are 4 and 5 (after subtracting the background fluorescence
reading) for H2B binding and 4.1 and 11.6 for H3 binding in
wild-type and mutant neutrophils, respectively. This represents a
25% increase of H2B binding and a 180% increase of H3 binding
in mutant neutrophils, which suggests that the NETs derived from
Hs2st-deficient mice might contain HS with greater binding ca-
FIG 4 Reduced bactericidal activity of Hs2st-deficient neutrophils. Bone marrow neutrophils (A) and LPS-elicited neutrophils (B) were collected from WT or
Hs2St-deficient mice. After challenge with GBS, CFU were measured at the indicated time points by serial plating. Data shown are means SEM from one of the
two independent experiments. (C) Reactive oxygen species production from bone marrow neutrophils after GBS stimulation detected by a luminol-based assay
(n	 2 mice). (D) Bone marrow neutrophils were directly lysed or stimulated with GBS for 30 min. Supernatants were collected to measure the total neutrophil
elastase (top) or released neutrophil elastase (bottom) by Western blot analysis. (E) Whole blood from WT and Hs2st-deficient mice was incubated with pHrodo
red-labeled GBS (MOI of 100) for 1 h at 37°C (phagocytosis) or 4°C (control). Neutrophils were fixed and subjected to flow cytometry to measure internalized
GBS. (F) LPS-elicited neutrophils were stimulated with GBS at an MOI of 10 for 2 h, washed, fixed, and stained with H2A/H2B MAb to visualize NET formation.
Differences between groups were calculated by an unpaired t test. **, P 0.01; *, P 0.05 (A, B, C, and F).
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pacity for histones (Fig. 5D). To better assess the effect of Hs2st
deficiency on histone binding, we also examined binding to Hs2st-
deficient endothelial cells, which express HS in much higher
quantities than neutrophils. Indeed, histones showed strong bind-
ing to endothelial cells, and both histones H2B and H3 bound HS
expressed on the surface of Hs2st-deficient endothelial cells at a
level 2-fold greater than that seen with wild-type endothelial cells
(Fig. 5E).
DISCUSSION
Neutrophils are typically the first immune cells to arrive in large
numbers at infection sites in response to microbe-derived che-
motactic signals and cytokines secreted by tissue-resident cells.
Circulating neutrophils first engage the microvascular endothe-
lium close to the inflammatory site and, after rolling on the endo-
thelium, extravasate into the tissue (31, 32). Once in the tissues,
neutrophils can be fully activated to combat and constrain infec-
tions and orchestrate other cells of the immune system. The ab-
sence of neutrophils or impairment of neutrophil recruitment and
activation can allow access of invading pathogens to the systemic
circulation and increase the risk of fatal sepsis. We previously
found that altered sulfation on endothelial cell HS by inactivation
of uronyl 2-O-sulfotransferase (Hs2st) promoted neutrophil ad-
hesion and extravasation in a sterile inflammation model medi-
ated by enhanced chemokine and L-selectin binding (11). Here,
we unexpectedly found that Hs2st-deficient mice did not experi-
ence an immune benefit from the accelerated recruitment of neu-
trophils but instead were more susceptible to infection with live
bacteria. This phenotype reflects a combination of increased en-
dothelial cell death and barrier dysfunction and reduced NET-
mediated neutrophil killing.
The structure of NETs is crucial in bacterial entrapment and
FIG 5 Reduced extracellular-trap (NET) formation in Hs2st-deficient neutrophils. (A) Human neutrophils were treated with 25 nM PMA for 3 h to allow NET
formation, treated with heparan lyase III (5 mU/ml), fixed, and stained with mouse anti-stub heparan sulfate MAb, rabbit anti-myeloperoxidase PAb, and DAPI,
followed by appropriate fluorochrome-conjugated secondary antibodies. (B) Human neutrophils were treated with 25 nM PMA for 3 h to induce NET formation
and then treated with DNase I (10 U/ml) or heparan lyase I and III (5 mU/ml) for 30 min at 37°C, followed by incubation with GBS for 30 min. Surviving GBS
were enumerated by serial plating. Differences between groups were calculated by unpaired t test. **, P 0.01; *, P 0.05. (C) Scanning electron microscopy
image of NETs produced by the PMA-activated neutrophils collected from WT or Hs2st-deficient mice. (D) Binding of histone H2B and H3 (both at 5 g/ml)
to peripheral neutrophils isolated from WT and Hs2st-deficient mice. (E) Binding of histone H2B and H3 (both at 5g/ml) to endothelial cells isolated from WT
and Hs2st-deficient mice.
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provides a high local concentration of extracellular antimicrobial
factors. HS is detected in NETs, overlapping in distribution with
the well-characterized microbicidal enzyme MPO (Fig. 5A). Re-
moval of neutrophil surface HS by heparin lyase treatment re-
duced neutrophil NET-mediated bactericidal activities, suggest-
ing that the origin of the HS in the NET is cell surface HSPGs (33)
(Fig. 5B). Direct bacterial killing has previously been linked to
highly toxic modified histones (34, 35). Recently, exogenously ad-
ministered nonanticoagulant heparin (a highly sulfated form of
HS) was found to colocalize with NETs, possibly through binding
to the NET histones, with consequent reduction of the cytotoxic-
ity of the heparin-bound histone (21). In accordance with the
poor bactericidal activity of Hs2st-deficient neutrophils, inactiva-
tion of Hs2st was associated with increased histone binding to
neutrophil surface HS (Fig. 5D and E). Therefore, in addition to
the reduced NET formation, sequestering of histones on the HS
may further contribute to the impaired bactericidal activity of
Hs2st-deficient neutrophils.
Generally reduction of sulfation on HS decreases its binding
affinity for most ligands, presumably through removal of nega-
tively charged domains mediating key electrostatic interactions.
However, the net charge of HS extracted from the Hs2st-deficient
cells is similar to that from wild-type cells due to increased N-
sulfation and 6-O-sulfation of the glucosamine residues, which
apparently enhances the interaction of the highly positively
charged histones, as observed previously for IL-8 (11). Interac-
tions between cell surface proteoglycans and histones or neutro-
phil granule proteases have been demonstrated (14, 20, 36, 37);
however, whether proteoglycans are a component of NETs and
whether HS sulfation may modulate the quantity, location, or
function of histones on NETs had not been addressed previously.
Our data indicate that inactivation of Hs2st on neutrophils may
impair their bactericidal activity through reduced NET formation
and potentially enhance sequestration of histone from delivery to
the bacterial cell wall target. Under pathological conditions in
which there is significant cell activation or death, histones are
released into the circulation, where they can exert cytotoxic activ-
ity on vascular endothelium (22, 38). Histone release also has been
suggested to trigger a feedback cascade, resulting in more cell
death and additional release of histones (39). Enhanced adherence
of GBS to Hs2st-deficient endothelial cells led to more cell death
upon infection (Fig. 2C and D). Should histone release be trig-
gered in this context, the increased binding of histones (Fig. 5E)
could exacerbate endothelial cell death and microvascular dys-
function upon GBS infection.
Recognized as a danger-associated molecular pattern (DAMP),
extracellular histones can modulate and amplify the inflammatory
response through Toll-like receptor-2 (TLR-2), TLR-4, and
NLRP3 inflammasome activation (40–42). Hs2st-deficient mac-
rophages responded normally to TLR stimuli (Fig. 3); however,
Hs2st-deficeint neutrophils were significantly less capable of kill-
ing GBS in vitro (Fig. 4), consistent with the observed innate im-
mune defect in vivo.
In summary, we have demonstrated that loss of brain endothe-
lial cell integrity and reduced NET-mediated host defense may
combine to yield the unexpected susceptibility of Hs2St-deficient
mice to GBS infection. Inactivation of Hs2st in neutrophils also
impacts the binding capacity of histones, a critical antimicrobial
molecule and structure on the NETs, revealing an unexplored role
for HS in neutrophil NET biology.
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